Search for other papers by Rossella Cannarella in
Google Scholar
PubMed
Search for other papers by Teresa Mattina in
Google Scholar
PubMed
Search for other papers by Rosita A Condorelli in
Google Scholar
PubMed
Search for other papers by Laura M Mongioì in
Google Scholar
PubMed
Search for other papers by Giuseppe Pandini in
Google Scholar
PubMed
Search for other papers by Sandro La Vignera in
Google Scholar
PubMed
Search for other papers by Aldo E Calogero in
Google Scholar
PubMed
Introduction Insulin-like growth factor 1 receptor ( IGF1R ) gene, made up of 315,991 base pairs, maps on the 15q26.3 chromosome. It encodes for a protein with a tyrosine kinase domain, which binds the IGF1 and is responsible for its
Search for other papers by Giulia Bresciani in
Google Scholar
PubMed
Search for other papers by Angeliki Ditsiou in
Google Scholar
PubMed
Search for other papers by Chiara Cilibrasi in
Google Scholar
PubMed
Search for other papers by Viviana Vella in
Google Scholar
PubMed
Search for other papers by Federico Rea in
Google Scholar
PubMed
Search for other papers by Marco Schiavon in
Google Scholar
PubMed
Search for other papers by Narciso Giorgio Cavallesco in
Google Scholar
PubMed
Search for other papers by Georgios Giamas in
Google Scholar
PubMed
Search for other papers by Maria Chiara Zatelli in
Google Scholar
PubMed
Search for other papers by Teresa Gagliano in
Google Scholar
PubMed
able to significantly counteract caspase 3/7 activity promoted by 5 μM sunitinib ( P < 0.00001). Effects of sunitinib on EGFR and IGF1R phosphorylation To further investigate the mechanisms of action by which sunitinib exerts its effects on BP
Search for other papers by Doron Weinstein in
Google Scholar
PubMed
Search for other papers by Rive Sarfstein in
Google Scholar
PubMed
Search for other papers by Zvi Laron in
Google Scholar
PubMed
Search for other papers by Haim Werner in
Google Scholar
PubMed
, and experimental evidence suggests an association between IGF system components and PCa development (1) . In particular, a close functional connection has been identified between the IGF1 receptor (IGF1R), a transmembrane heterotetramer primarily
Search for other papers by A J Varewijck in
Google Scholar
PubMed
Search for other papers by A J van der Lely in
Google Scholar
PubMed
Search for other papers by S J C M M Neggers in
Google Scholar
PubMed
Search for other papers by S W J Lamberts in
Google Scholar
PubMed
Search for other papers by L J Hofland in
Google Scholar
PubMed
Search for other papers by J A M J L Janssen in
Google Scholar
PubMed
are still used to assess IGF1 bioactivity has been the lack of reliable assays to measure IGF1 bioactivity. An IGF1 receptor (IGF1R)-specific kinase receptor activation (KIRA) assay has been developed as an alternative method to evaluate circulating
Search for other papers by R Solomon-Zemler in
Google Scholar
PubMed
Raphael Recanati Genetic Institute, Rabin Medical Center – Beilinson Hospital, Petach Tikva, Israel
Felsenstein Medical Research Center, Petach Tikva, Israel
Pediatric Genetics, Schneider Children’s Medical Center of Israel, Petach Tikva, Israel
Search for other papers by L Basel-Vanagaite in
Google Scholar
PubMed
Search for other papers by D Steier in
Google Scholar
PubMed
Search for other papers by S Yakar in
Google Scholar
PubMed
Search for other papers by E Mel in
Google Scholar
PubMed
Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, Schneider Children’s Medical Center of Israel, Petach Tikva, Israel
Search for other papers by M Phillip in
Google Scholar
PubMed
Search for other papers by L Bazak in
Google Scholar
PubMed
Search for other papers by D Bercovich in
Google Scholar
PubMed
Shalom and VardaYoran Institute for Human Genome Research, Tel Aviv University, Tel Aviv, Israel
Search for other papers by H Werner in
Google Scholar
PubMed
Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, Schneider Children’s Medical Center of Israel, Petach Tikva, Israel
Search for other papers by L de Vries in
Google Scholar
PubMed
specific (genetic or other) defect can be recognized. Growth and developmental conditions under the umbrella of congenital insulin-like growth factor-1 ( IGF-1 ) deficiencies include: (i) growth hormone (GH) releasing hormone-receptor ( GHRH-R ) defect
Search for other papers by R C S van Adrichem in
Google Scholar
PubMed
Search for other papers by L J Hofland in
Google Scholar
PubMed
Search for other papers by R A Feelders in
Google Scholar
PubMed
Search for other papers by M C De Martino in
Google Scholar
PubMed
Search for other papers by P M van Koetsveld in
Google Scholar
PubMed
Search for other papers by C H J van Eijck in
Google Scholar
PubMed
Search for other papers by R R de Krijger in
Google Scholar
PubMed
Search for other papers by D M Sprij-Mooij in
Google Scholar
PubMed
Search for other papers by J A M J L Janssen in
Google Scholar
PubMed
Search for other papers by W W de Herder in
Google Scholar
PubMed
functions in normal tissues and tumors, plays an important role in the pathophysiology of GEP NETs (2) . The IGF system consists of different IGF-related genes: two ligands (IGF1 and IGF2), two IGF receptors (IGF1R and IGF2R), two insulin receptors (IR
Department of Diabetes, Metabolism, and Endocrinology, Showa University School of Medicine, Shinagawa, Tokyo, Japan
Search for other papers by Yusaku Mori in
Google Scholar
PubMed
Search for other papers by Eunhyoung Ko in
Google Scholar
PubMed
Search for other papers by Rudolf Furrer in
Google Scholar
PubMed
Search for other papers by Linda C Qu in
Google Scholar
PubMed
Search for other papers by Stuart C Wiber in
Google Scholar
PubMed
Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada
Division of Endocrinology and Metabolism, Leadership Centre for Diabetes, Mount Sinai Hospital, Toronto, Ontario, Canada
Search for other papers by I George Fantus in
Google Scholar
PubMed
Search for other papers by Mario Thevis in
Google Scholar
PubMed
Department of Pathology, Humber River Regional Hospital, Toronto, Ontario, Canada
Search for other papers by Alan Medline in
Google Scholar
PubMed
Search for other papers by Adria Giacca in
Google Scholar
PubMed
insulin-like growth factor-1 receptor (IGF-1R) are highly expressed in most breast cancers ( 19 ). In vitro studies show that glargine, which has a higher affinity for the IGF-1R than human insulin, also has a greater mitotic effect in breast cancer cell
Search for other papers by María Dolores Rodríguez Arnao in
Google Scholar
PubMed
Search for other papers by Amparo Rodríguez Sánchez in
Google Scholar
PubMed
Search for other papers by Ignacio Díez López in
Google Scholar
PubMed
Search for other papers by Joaquín Ramírez Fernández in
Google Scholar
PubMed
Search for other papers by Jose Antonio Bermúdez de la Vega in
Google Scholar
PubMed
Search for other papers by Diego Yeste Fernández in
Google Scholar
PubMed
Search for other papers by María Chueca Guindulain in
Google Scholar
PubMed
Search for other papers by Raquel Corripio Collado in
Google Scholar
PubMed
Search for other papers by Jacobo Pérez Sánchez in
Google Scholar
PubMed
Search for other papers by Ana Fernández González in
Google Scholar
PubMed
Search for other papers by ECOS Spain Study Collaborative Investigator Group in
Google Scholar
PubMed
Introduction Since the 60s, GH has been the mainstay of treatment for children with GH deficiency (GHD) ( 1 ). With the discovery of recombinant human growth hormone (r-hGH), the treatment has been extended to other conditions, such as Turner
Department of Anatomy and UMIB (Unit for Multidisciplinary Biomedical Research) of ICBAS, Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Department of Endocrinology, University of Porto, Porto, 4050-313, Portugal
Search for other papers by Sofia S Pereira in
Google Scholar
PubMed
Search for other papers by Tiago Morais in
Google Scholar
PubMed
Search for other papers by Madalena M Costa in
Google Scholar
PubMed
Search for other papers by Mariana P Monteiro in
Google Scholar
PubMed
Department of Anatomy and UMIB (Unit for Multidisciplinary Biomedical Research) of ICBAS, Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Department of Endocrinology, University of Porto, Porto, 4050-313, Portugal
Search for other papers by Duarte Pignatelli in
Google Scholar
PubMed
proliferation (Ki-67), and cell adhesion (E-cadherin and β-catenin), and the growth factor IGF2 and its receptor IGF1R. Subjects and methods Patients and tumors Paraffin-embedded adrenal samples from a total of 43 patients were used. These included ACA samples
Search for other papers by Wenjun Long in
Google Scholar
PubMed
Search for other papers by Tuo Zhou in
Google Scholar
PubMed
Search for other papers by Xiuping Xuan in
Google Scholar
PubMed
Search for other papers by Qiuli Cao in
Google Scholar
PubMed
Search for other papers by Zuojie Luo in
Google Scholar
PubMed
Search for other papers by Yingfen Qin in
Google Scholar
PubMed
Search for other papers by Qin Ning in
Google Scholar
PubMed
Search for other papers by Xiaoping Luo in
Google Scholar
PubMed
Search for other papers by Xuemei Xie in
Google Scholar
PubMed
room temperature and then incubated with primary antibodies including LRP6 (1:1000 dilution; Abcam), β-catenin (1:2000 dilution; Abcam), P70S6K (1:2000 dilution; Abcam), IGF-1R (1:500 dilution; Abcam), IR (1:1000 dilution; Cell Signaling Technology